Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Organization. Hepatitis C. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed 27 July 2020.
Centers for Disease Control and Prevention. Hepatitis C questions and answers for health professionals. 2020. Available at : https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Accessed 7 Aug 2020.
Dirks M, Haag K, Pflugrad H, Tryc AB, Schuppner R, Wedemeyer H, et al. Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. J Viral Hepat. 2019;26:422–31. https://doi.org/10.1111/jvh.12979.
Zignego AL, Ferri C, Pileri SA. Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39:2–17. https://doi.org/10.1016/j.dld.2006.06.008.
World Health Organization. WHO urges countries to invest in eliminating hepatitis. 2019. Available at: https://www.who.int/news-room/detail/26-07-2019-who-urges-countries-to-invest-in-eliminating-hepatitis. Accessed 26 July 2019.
Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis – United States. 2016. Available at: https://www.cdc.gov/hepatitis/statistics/2016surveillance/commentary.htm. Accessed 16 Apr 2018.
Eurostat. EU hepatitis death rate stable. Accessed at: http://ec.europa.eu/eurostat/web/products-eurostat-news/-/EDN-20180728-1?
Fedeli U, Grande E, Grippo F, Frova L. Mortality associated with hepatitis C and hepatitis B virus infection: a nationwide study on multiple causes of death data. World J Gastroenterol. 2017;23:1866–71. https://doi.org/10.3748/wjg.v23.i10.1866.
World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. 2016. Available at: http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf. Accessed June 2016.
Polaris Observatory. The authoritative resource for epidemiological data, modeling tools, training, and decision analytics to support global elimination of hepatitis B and C by 2030. Available at: http://www.hepbunited.org/assets/Webinar-Slides/8b54a78215/POLARIS-Brief-181217.pdf.
Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry [published online ahead of print, 2020 May 21]. J Hepatol. 2020;S0168–8278(20):30305–6. https://doi.org/10.1016/j.jhep.2020.05.013.
Allenza contro l’Epatite. Documento di posizione SCREENING CONGIUNTO HCV/COVID-19. 2020. Available at: https://www.epatitec.info/cm-files/2020/06/22/position-paper-ace-screening-congiunto-hcv-covid-19.pdf. Accessed 22 June 2020.
European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018;69:461–511. https://doi.org/10.1016/j.jhep.2018.03.026.
Alleanza Contro l’Epatite. ALLEANZA CONTRO L’EPATITE 2019 POSITION PAPER. 2019. Available at: https://www.epac.it/cm-files/2019/10/03/position-paper-hcv-def.pdf. Accessed 3 Oct 2019.
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45–57. https://doi.org/10.1016/j.jhep.2014.07.027.
Saraswat V, Norris S, de Knegt RJ, Sanchez Avila JF, Sonderup M, Zuckerman E, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat. 2015;1:6–25. https://doi.org/10.1111/jvh.12350.
Maaroufi A, Vince A, Himatt SM, Mohamed R, Fung J, Opare-Sem O, et al. Historical epidemiology of hepatitis C virus in select countries-volume 4. J Viral Hepat. 2017;24:8–24. https://doi.org/10.1111/jvh.12762.
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089–102. https://doi.org/10.1016/S0140-6736(16)30466-4.
Tanaka H, Tsukuma H, Yamano H, Oshima A, Shibata H. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer. 2004;112:1075–80. https://doi.org/10.1002/ijc.20507.
World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014. Available at: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/. Accessed Apr 2014.
World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version July 2018. Available at: https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2018/en/. Accessed July 2018.
World Health Organization. Sixty-ninth world health assembly. Draft global health sector strategies. Viral hepatitis, 2016–2021. 2016. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf. Accessed June 2016.
Ramadori G, Meier V. Hepatitis C virus infection: 10 years after the discovery of the virus. Eur J Gastroenterol Hepatol. 2001;13:465–71. https://doi.org/10.1097/00042737-200105000-00001.
World Health Organization. Global hepatitis report. 2017. Available at: http://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed Apr 2017.
World Health Organization. Global Status Report on Blood Safety and Availability 2016. Available at: http://apps.who.int/iris/bitstream/10665/254987/1/9789241565431-eng.pdf?ua=1.
Piccinini V, Facco G, Catalano L, Pupella S, Grazzini G. Transfusion transmitted infection in Italy: blood donors epidemiological surveillance. Report 2013. Istituto Superiore di Sanità. Rapporti ISTISAN 14/26. 2013.
Fabrizi F, Martin P, Mess P. Control of HCV, HBV and HIV infections in hemodialysis. Giornale Italiano di Nefrologia. G Ital Nefrol. 2013;30(4):gin/30.4.11.
Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65:2335–42. https://doi.org/10.1111/j.1523-1755.2004.00649.x.
Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S. Lazio Dialysis Registry. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis. 2006;48:629–37. https://doi.org/10.1053/j.ajkd.2006.07.004.
Saab S, Rheem J, Sundaram V. Hepatitis C infection in the elderly. Dig Dis Sci. 2015;60:3170–80. https://doi.org/10.1007/s10620-015-3717-6.
Joy JB, McCloskey RM, Nguyen T, Liang RH, Khudyakov Y, Olmstead A, et al. The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study. Lancet Infect Dis. 2016;16:698–702.
Manjelievskaia J, Brown D, Shriver CD, Zhu K. CDC screening recommendation for baby boomers and hepatitis C virus testing in the US military health system. Public Health Rep. 2017;132(5):579–84. https://doi.org/10.1177/0033354917719446.
Shiffman ML. The next wave of hepatitis C virus: the epidemic of intravenous drug use. Liv Int. 38:34–9. https://doi.org/10.1111/liv.13647.
Vandelli C, Renzo F, Romanò L, Tisminetzky S, De Palma M, Stroffolini T, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol. 2004;99:855–9. https://doi.org/10.1111/j.1572-0241.2004.04150.x.
Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol. 2005;100:821–4. https://doi.org/10.1111/j.1572-0241.2005.40879.x.
Terrault NA. Sexual activity as risk factor for hepatitis C. Hepatology. 2002;36:S99–105. https://doi.org/10.1053/jhep.2002.36797.
Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013;57:881–9. https://doi.org/10.1002/hep.26164.
Karageorgopoulos DE, Allen J, Bhagani S. Hepatitis C in human immunodeficiency virus co-infected individuals: is this still a “special population”? World J Hepatol. 2015;7:1936–52. https://doi.org/10.4254/wjh.v7.i15.1936.
Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J, et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect. 2008;84:111–5. https://doi.org/10.1136/sti.2007.027334.
Wandeler G, Gsponer T, Bregenzer A, Günthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55:1408–16. https://doi.org/10.1093/cid/cis694.
van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136:1609–17.
Puglia M, Stasi C, Da Frè M, Voller F. Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany. Braz J Infect Dis. 2016;20:330–4. https://doi.org/10.1016/j.bjid.2015.11.007.
Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59:765–73. https://doi.org/10.1093/cid/ciu447.
Indolfi G, Nesi A, Resti M. Intrafamilial transmission of hepatitis C virus. J Med Virol. 2013;85:608–14. https://doi.org/10.1002/jmv.23522.
Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev. 2003;16:546–68. https://doi.org/10.1128/cmr.16.3.546-568.2003.
World Health Organization. Hepatitis C in the WHO European region. Fact sheet – July 2018. Available at: http://www.euro.who.int/__data/assets/pdf_file/0009/377253/fact-sheet-hepatitis-c-eng.pdf?ua=1. Accessed July 2018.
Centers for Disease Control and Prevention. Vital Signs: Evaluation of Hepatitis C Virus Infection Testing and Reporting — Eight U.S. Sites, 2005–2011. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6218a4.htm. Accessed 10 May 2013.
American Association for the Study of Liver Diseases, Infectious Diseases Society of America. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. HCV Testing and Linkage to Care. 2017. Available at: http://www.hcvguidelines.org/full-report/hcv-testing-and-linkage-care. Accessed 25 June 2019.
Crespo J, Cuadrado A, Perelló C, Cabezas J, Llerena S, Llorca J, et al. Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: data for designing a cost-effective elimination policy in Spain. J Viral Hepat. 2020;27:360–70. https://doi.org/10.1111/jvh.13238.
U.S. Preventive Services Task Force. Draft recommendation statement and draft evidence review: screening for hepatitis C virus infection. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/draft-evidence-review/hepatitis-c-screening1. Accessed 27 Aug 2019.